Latest News & Features
Americas
Biogen and the University of Zurich have accused New York-based Creative Biolabs of unlawfully selling copies of Biogen’s aducanumab antibody. 19 March 2020
Medtech
Richard Fawcett, senior associate at Powell Gilbert, outlines why the UK patent system poses no obstacle to the UK government’s rallying call for ventilator production amid the COVID-19 pandemic. 19 March 2020
Americas
The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court. 19 March 2020
Americas
Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits. 19 March 2020
Americas
German authorities have reacted angrily to media reports that US President Donald Trump offered $1 billion to CureVac, a Germany-based company seeking a COVID-19 vaccine, to move its operations to the US. 17 March 2020
Big Pharma
The US Court of Appeals for the Federal Circuit has rescued one Boehringer Ingelheim patent, covering a type 2 diabetes treatment, from invalidation but affirmed a New Jersey district court’s cancellation of two others. 17 March 2020
Big Pharma
The World Health Organization has launched a Solidarity Response Fund, offering companies, foundations and individuals the chance to donate to the WHO’s global response to the ongoing COVID-19 pandemic. 16 March 2020
Europe
An English High Court judge has issued an injunction against Edwards Lifesciences, handing a victory to Abbott Laboratories subsidiary Evalve. 13 March 2020
Americas
The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography. 12 March 2020
Big Pharma
The UK Competition and Markets Authority has welcomed a Court of Appeal ruling allowing it to press ahead with cases against Pfizer and Flynn Pharma over the unfair pricing of an epilepsy treatment. 12 March 2020